About pasithea therapeutics corp - KTTA
Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Lawrence J. Steinman on May 12, 2020 and is headquartered in Miami Beach, FL.
KTTA At a Glance
Pasithea Therapeutics Corp.
1111 Lincoln Road
Miami Beach, Florida 33139
| Phone | 1-786-877-3380 | Revenue | 0.00 | |
| Industry | Pharmaceuticals: Major | Net Income | -13,904,584.00 | |
| Sector | Health Technology | Employees | 4 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
KTTA Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | 0.297 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 0.255 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | N/A |
KTTA Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | -3,476,146.00 |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
KTTA Liquidity
| Current Ratio | 6.58 |
| Quick Ratio | 6.58 |
| Cash Ratio | 6.182 |
KTTA Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -65.927 |
| Return on Equity | -72.835 |
| Return on Total Capital | -94.06 |
| Return on Invested Capital | -72.835 |
KTTA Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | N/A |
| Total Debt to Total Assets | N/A |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |